Review
Jul 2026
SLC25A51 and mitochondrial NAD⁺ transport in acute myeloid leukemia: mechanisms, therapeutic potential, and translational perspectives
SLC25A51 represents a promising metabolic target with potential to overcome therapeutic resistance and improve patient outcomes in AML, and its potential implications across distinct genetic subtypes of AML are discussed, thereby highlighting key directions for future translational research.
Chun-Meng Rong, Ruixiu Chen, Hanqi Lou et al.
· Human Cell · 0 citations